Form D · Biotechnology
Leading Biosciences, Inc.
Carlsbad, CA · CIK 0001862235
Offering snapshot reported May 18, 2021 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 27, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2021 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.4M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-399714
Source: Form D, filed May 18, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Dawson | Executive |
| Stephanie Diaz | Director |
| Jd Finley | Executive |
| Thomas Hallam | Director, Executive |
| James R. Neal | Director |
| Robert J. Trenschel | Director |
| Don Williams | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5800 Armada Dr., Suite 210
Carlsbad, CA, 92008
Carlsbad, CA, 92008